# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-21-012028
Filing Date
2021-04-07
Accepted
2021-04-07 17:08:25
Documents
6
Period of Report
2021-05-20

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | nc10020142x1_def14a.htm | DEF 14A | 1040227
2 |  | nc10020142x1_pc1.jpg | GRAPHIC | 619153
3 |  | nc10020142x1_pc2.jpg | GRAPHIC | 482750
4 |  | nc10020142x1_piecharts.jpg | GRAPHIC | 126427
5 |  | nc10020142x1_sig.jpg | GRAPHIC | 16848
6 |  | nc100200142x1_sigx1.jpg | GRAPHIC | 21356
| Complete submission text file | 0001140361-21-012028.txt |  | 2784516

Mailing Address 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE CA 91362
Business Address 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE CA 91362 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50865 | Film No.: 21812869
SIC: 2834 Pharmaceutical Preparations